ATI RN
Physical Exam Cardiovascular System
1. What is a condition where the lung's alveoli are permanently enlarged and damaged, leading to shortness of breath?
- A. Emphysema
- B. Bronchitis
- C. Atelectasis
- D. Pulmonary fibrosis
Correct answer: A
Rationale: Emphysema is the correct answer. It is a chronic lung condition characterized by the permanent enlargement and damage of the alveoli, leading to shortness of breath and impaired oxygen exchange. Bronchitis is the inflammation of the bronchial tubes, not specifically related to alveolar damage. Atelectasis is the collapse of lung tissue, not enlargement. Pulmonary fibrosis involves scarring and thickening of lung tissue, different from the alveolar damage seen in emphysema.
2. What is the buildup of plaque in the arteries that can lead to heart attack, stroke, and other cardiovascular diseases?
- A. Atherosclerosis
- B. Arteriosclerosis
- C. Hypertension
- D. Diabetes
Correct answer: A
Rationale: Atherosclerosis is the correct answer. It is the buildup of plaque in the arteries, leading to the narrowing of blood vessels, reduced blood flow, and an increased risk of heart attacks, strokes, and other cardiovascular diseases. Arteriosclerosis (choice B) refers to the hardening and thickening of arterial walls, while hypertension (choice C) is high blood pressure, and diabetes (choice D) is a metabolic disorder characterized by high blood sugar levels. Therefore, choices B, C, and D are incorrect in the context of the question.
3. What is a condition where the lung's air sacs become inflamed and fill with fluid or pus, causing cough, fever, chills, and difficulty breathing?
- A. Pneumonia
- B. Tuberculosis
- C. Asthma
- D. Bronchitis
Correct answer: A
Rationale: Pneumonia is the correct answer. It is an infection that inflames the air sacs in one or both lungs, leading to the accumulation of fluid or pus, which results in symptoms such as cough, fever, chills, and difficulty breathing. Tuberculosis (choice B) is a bacterial infection affecting the lungs but does not typically cause the same acute symptoms as described. Asthma (choice C) is a chronic respiratory condition characterized by inflammation and narrowing of the airways, not specifically involving the air sacs. Bronchitis (choice D) is an inflammation of the bronchial tubes, not the air sacs in the lungs, and does not typically cause the same symptoms as pneumonia.
4. The client on spironolactone (Aldactone) has a potassium level of 5.8 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer a potassium supplement.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: With a potassium level of 5.8 mEq/L, which is high, the priority action for the nurse is to hold the spironolactone. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, it is crucial to prevent exacerbating hyperkalemia by discontinuing the medication. Notifying the healthcare provider is necessary for further guidance and potential adjustments to the treatment plan. Administering a potassium supplement (Choice B) would be contraindicated since the client already has elevated potassium levels. Continuing the spironolactone as ordered (Choice C) can worsen hyperkalemia. Increasing the dose of spironolactone (Choice D) would be unsafe and exacerbate the high potassium levels.
5. The healthcare provider is monitoring a client on an ACE inhibitor. What lab value is most important to monitor?
- A. Potassium
- B. Sodium
- C. Creatinine
- D. Calcium
Correct answer: A
Rationale: The correct answer is A: Potassium. When a client is on an ACE inhibitor, it is crucial to monitor potassium levels because ACE inhibitors can lead to an increase in potassium, potentially causing hyperkalemia. Monitoring sodium levels (Choice B) is not as critical in this scenario. Creatinine levels (Choice C) are important for assessing kidney function but are not the most crucial lab value to monitor with ACE inhibitors. Calcium levels (Choice D) are not directly affected by ACE inhibitors and are not the priority for monitoring in this case.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access